The FDA approved the first nasal spray for the emergency treatment of allergic reactions in adult and certain pediatric patients.| U.S. Food and Drug Administration
The FDA approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.| U.S. Food and Drug Administration
Public health agencies have refused to study or to publicly release data comparing the health outcomes of vaccinated and unvaccinated children, according to experts who spoke during Monday’s U.S. Senate roundtable discussion on “Federal Health Agencies and the COVID Cartel.”| Children's Health Defense
The Food and Drug Administration has approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease.| U.S. Food and Drug Administration
The FDA approved the first drug for the prevention of RSV lower respiratory tract disease in babies and toddlers.| U.S. Food and Drug Administration
Eisai has started a rolling application seeking U.S. FDA approval of an under-the-skin injection version of Leqembi for early Alzheimer’s.| Alzheimer's News Today
FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS). Qalsody is an antisense oligonucleotide that targets SOD1 mRNA to reduce the synthesis of SOD1 protein. The approval was based o| U.S. Food and Drug Administration
The FDA approved Zepbound (tirzepatide) for chronic weight management in adults with obesity or are overweight.| U.S. Food and Drug Administration
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.| U.S. Food and Drug Administration